Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Karikó, Katalin, Muramatsu, Hiromi, Welsh, Frank A, Ludwig, János, Kato, Hiroki, Akira, Shizuo, Weissman, Drew·2008·Molecular Therapy
DOI 10.1038/mt.2008.200

Cited by (1,003)

Items 401–500 of 1,003

  1. Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering
    Marshall Scott Padilla, Kaitlin Mrksich, Yiming Wang, Rebecca M. Haley, Jacqueline J. Li, Emily Laura Han, Rakan D. El-Mayta, Emily H. Kim, Sofia Dias, Ningqiang Gong et al. · 2025 · Nature Communications
  2. Perspectives on RNA Vaccine Candidates for COVID-19
    Pobitra Borah, Pran Kishore Deb, Nizar A. Al‐Shar’i, Lina A. Dahabiyeh, Katharigatta Narayanaswamy Venugopala, Vinayak Singh, Pottathil Shinu, Snawar Hussain, Satyendra Deka, Balakumar Chandrasekaran et al. · 2021 · Frontiers in Molecular Biosciences
  3. Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic
    Ziqi Wang, Kai Cui, Ulrich Costabel, Xiaoju Zhang · 2022 · Exploration
  4. Advanced delivery systems for peptide antibiotics
    Angela Cesaro, Shuang‐Zhe Lin, Norbert Pardi, César de la Fuente‐Núñez · 2023 · Advanced Drug Delivery Reviews
  5. Simultaneous nanopore profiling of mRNA m6A and pseudouridine reveals translation coordination
    Sihao Huang, Adam C. Wylder, Tao Pan · 2024 · Nature Biotechnology
  6. RNA-Based Tools for Nuclear Reprogramming and Lineage-Conversion: Towards Clinical Applications
    J. A. Bernal · 2013 · Journal of Cardiovascular Translational Research
  7. The Epitranscriptome and Innate Immunity
    Mary A. O’Connell, Niamh Mannion, Liam P. Keegan · 2015 · PLoS Genetics
  8. CAR T-Cell Production Using Nonviral Approaches
    Viktor Lukjanov, Irena Koutná, Pavel Šimara · 2021 · Journal of Immunology Research
  9. Exploring the epitranscriptome by native RNA sequencing
    Oguzhan Begik, John S. Mattick, Eva Maria Novoa · 2022 · RNA
  10. Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
    Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, Vasso Apostolopoulos, Chirag Amrutlal Patel, Rajashri Bezbaruah, Aayushi Patel, Zhe‐Sheng Chen · 2022 · Frontiers in Immunology
  11. mRNA modifications: Dynamic regulators of gene expression?
    Thomas Philipp Hoernes, Alexander Hüttenhofer, Matthias David Erlacher · 2016 · RNA Biology
  12. Cap analogs modified with 1,2-dithiodiphosphate moiety protect mRNA from decapping and enhance its translational potential
    Malwina Strenkowska, Renata Grzela, Maciej Majewski, Katarzyna Wnek, Joanna Kowalska, Maciej Łukaszewicz, Joanna Zuberek, Edward Darżynkiewicz, Andreas N. Kuhn, Uğur Şahin et al. · 2016 · Nucleic Acids Research
  13. Latest Development on RNA-Based Drugs and Vaccines
    Kenneth H. Lundstrom · 2018 · Future Science OA
  14. Therapeutic RNA Delivery for COVID and Other Diseases
    Curtis N. Dobrowolski, Kalina Paunovska, Marine Z. C. Hatit, Melissa P. Lokugamage, James E. Dahlman · 2021 · Advanced Healthcare Materials
  15. N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein products
    Kyusik Q. Kim, Bhagyashri D. Burgute, Shin‐Cheng Tzeng, Crystal Jing, Courtney F. Jungers, Junya Zhang, Liewei L. Yan, Richard David Vierstra, Sergej Djuranović, Bradley S. Evans et al. · 2022 · Cell Reports
  16. mRNA-Based Therapeutics in Cancer Treatment
    Han Sun, Yu Zhang, Ge Wang, Wen Yang, Yingjie Xu · 2023 · Pharmaceutics
  17. The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses
    Konstantin Föhse, Büsra Geckin, Martijn Zoodsma, Gizem Kılıç, Zhaoli Liu, Rutger Jan Röring, Gijs J. Overheul, Josephine van de Maat, Ozlem Pinar Bulut, Jacobien J. Hoogerwerf et al. · 2023 · Clinical Immunology
  18. Combining an optimized mRNA template with a double purification process allows strong expression of in vitro transcribed mRNA
    Linares-Fernández, Sergio, Moreno, Julien, Lambert, Elise, Mercier-Gouy, Perrine, Vachez, Laetitia, Verrier, Bernard, Exposito, Jean-Yves · 2021 · Molecular Therapy - Nucleic Acids
  19. Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing
    Maryam Youssef, Cynthia Hitti, Julia Puppin Chaves Fulber, Amine Kamen · 2023 · Biomolecules
  20. Discovering and Mapping the Modified Nucleotides That Comprise the Epitranscriptome of mRNA
    Bastian Linder, Samie R. Jaffrey · 2019 · Cold Spring Harbor Perspectives in Biology
  21. Instrumental analysis of RNA modifications
    Yasemin Yoluç, Gregor Ammann, Pierre Barraud, Manasses Jora, Patrick A. Limbach, Yuri Motorin, Virginie Marchand, Carine Tisné, Kayla M. Borland, Stefanie M. Kellner · 2021 · Critical Reviews in Biochemistry and Molecular Biology
  22. Antigenic characterization of influenza and SARS-CoV-2 viruses
    Yang Wang, Cynthia Y. Tang, Xiu‐Feng Wan · 2021 · Analytical and Bioanalytical Chemistry
  23. RNA modification in mRNA cancer vaccines
    Yingxue Mei, Xiang Wang · 2023 · Clinical and Experimental Medicine
  24. Ongoing Clinical Trials of Nonviral siRNA Therapeutics
    Eshan A. Narasipura, Rachel VanKeulen‐Miller, Yutian Ma, Owen S. Fenton · 2023 · Bioconjugate Chemistry
  25. Current Status of Vaccines for Porcine Reproductive and Respiratory Syndrome: Interferon Response, Immunological Overview, and Future Prospects
    Jiuyi Li, Laura C. Miller, Yongming Sang · 2024 · Vaccines
  26. Understanding the impact of in vitro transcription byproducts and contaminants
    Robin Lenk, Werner Kleindienst, Gábor Tamás Szabó, Markus Baiersdörfer, Gábor Boros, Jason M. Keller, Azita J. Mahiny, Irena Vlatkovic · 2024 · Frontiers in Molecular Biosciences
  27. Post-transcriptional pseudouridylation in mRNA as well as in some major types of noncoding RNAs
    Adachi, Hironori, De Zoysa, Meemanage D., Yu, Yi-Tao · 2019 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  28. Review: Current trends, challenges, and success stories in adjuvant research
    Kentner L. Singleton, Ari Robin Joffe, Wolfgang W. Leitner · 2023 · Frontiers in Immunology
  29. The mRNA-LNP vaccines – the good, the bad and the ugly?
    Botond Z. Igyártó, Zhen Qin · 2024 · Frontiers in Immunology
  30. ROS‐Responsive Injectable Hydrogel Loaded with SLC7A11‐modRNA Inhibits Ferroptosis and Mitigates Intervertebral Disc Degeneration in Rats
    Tian Gao, Guangyu Xu, Tiancong Ma, Xiao Lu, Kaiwen Chen, Huanhuan Luo, Gang Chen, Jian Guo Song, Xiaosheng Ma, Wei En Fu et al. · 2024 · Advanced Healthcare Materials
  31. Precise and systematic end group chemistry modifications on PAMAM and poly(l-lysine) dendrimers to improve cytosolic delivery of mRNA
    Fanny Joubert, Michael J. Munson, Alan Sabirsh, R. England, Martin Hemmerling, Cameron Alexander, Marianne B. Ashford · 2023 · Journal of Controlled Release
  32. Antiangiogenic Therapeutic mRNA Delivery Using Lung-Selective Polymeric Nanomedicine for Lung Cancer Treatment
    Ngoc Duy Le, Bảo Lộc Nguyễn, Basavaraj Rudragouda Patil, HeeSang Chun, Siyoon Kim, Thi Oanh Oanh Nguyen, Sunil Kumar Mishra, Sudarshan Tandukar, Jae‐Hoon Chang, Dong Young Kim et al. · 2024 · ACS Nano
  33. RNA vaccines for cancer: Principles to practice
    Pablo Guasp, Charlotte Reiche, Zachary M. Sethna, Vinod P. Balachandran · 2024 · Cancer Cell
  34. Clinical development of therapeutic mRNA applications
    Magdalena M. Żak, Lior Zangi · 2025 · Molecular Therapy
  35. Pseudouridine RNA avoids immune detection through impaired endolysosomal processing and TLR engagement
    Marleen Bérouti, Mirko Wagner, Wilhelm Greulich, Ignazio Piseddu, Jan Gärtig, Larissa Hansbauer, Christoph Müller-Hermes, Matthias Heiß, Alexander Pichler, Annika J. Tölke et al. · 2025 · Cell
  36. Eukaryotic Translation Elongation is Modulated by Single Natural Nucleotide Derivatives in the Coding Sequences of mRNAs
    Thomas Philipp Hoernes, David Heimdörfer, Daniel Kostner, Klaus Faserl, Felix Nußbaumer, Raphael Plangger, Christoph Kreutz, Herbert H. Lindner, Matthias David Erlacher · 2019 · Genes
  37. The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines
    Wei, Jiao, Hui, Ai-Min · 2022 · Cancer Treatment Reviews
  38. mRNA, a Revolution in Biomedicine
    Bruno Baptista, Rita Carapito, Nabila Laroui, Chantal Pichon, Fani Pereira de Sousa · 2021 · Pharmaceutics
  39. Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy
    Yusi Wang, Rui Zhang, Lin Tang, Yang Li · 2022 · Pharmaceutics
  40. Development and applications of mRNA treatment based on lipid nanoparticles
    Zhe Wang, Wanting Ma, Xingxing Fu, Yanfei Qi, Yinan Zhao, Shubiao Zhang · 2023 · Biotechnology Advances
  41. Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates
    Maureen Buckley, Mariluz Araínga, Laura Maiorino, Ivan Susin Pires, Byungji Kim, Katarzyna Kaczmarek Michaels, Jonathan Dye, Kashif Qureshi, Yiming J. Zhang, Howard H. Mak et al. · 2025 · Molecular Therapy
  42. Design, Assembly, Production, and Transfection of Synthetic Modified mRNA
    Oh, Sanders, Kessler, John A. · 2018 · Methods
  43. The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
    Sonia Ndeupen, Zhen Qin, Sonya Jacobsen, Henri Estanbouli, Aurélie Bouteau, Botond Z. Igyártó · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  44. New Technologies for Influenza Vaccines
    Steven P. Rockman, Karen Laurie, Simone Parkes, Adam K. Wheatley, Ian Barr · 2020 · Microorganisms
  45. Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa
    Jie Tang, Larry Cai, Chuanfei Xu, Si Sun, Yuheng Liu, Joseph Rosenecker, Shan Guan · 2022 · Nanomaterials
  46. Delivering the CRISPR/Cas9 system for engineering gene therapies: Recent cargo and delivery approaches for clinical translation
    Ruth A. Foley, Ruby Alice Sims, Emily C. Duggan, Jessica K. Olmedo, Rachel Ma, Steven John Jonas · 2022 · Frontiers in Bioengineering and Biotechnology
  47. Deep learning models for predicting RNA degradation via dual crowdsourcing
    Hannah K. Wayment-Steele, Wipapat Kladwang, Andrew M. Watkins, Do Soon Kim, Bojan Tunguz, Walter Reade, Maggie Demkin, Jonathan Romano, Roger Wellington-Oguri, John J. Nicol et al. · 2022 · Nature Machine Intelligence
  48. Cardiac delivery of modified mRNA using lipid nanoparticles: Cellular targets and biodistribution after intramyocardial administration
    Maria Clara Isabel Labonia, Mariona Estapé Sentí, Petra H. van der Kraak, Maike A. D. Brans, Inge Dokter, T J Streef, Anke M. Smits, Anil Kumar Deshantri, Saskia C.A. de Jager, Raymond Michel Schiffelers et al. · 2024 · Journal of Controlled Release
  49. A Review on the Stability Challenges of Advanced Biologic Therapeutics
    Sruthi Sarvepalli, Shashank Reddy Pasika, Vartika Verma, Anusha Thumma, Sandeep Bolla, Pavan Kumar Nukala, Arun Butreddy, Pradeep Kumar Bolla · 2025 · Pharmaceutics
  50. A flexible, efficient, and scalable platform to produce circular RNAs as new therapeutics
    Huanhuan Y. Wei, Chuyun Chen, Kai Zhang, Zeyang Li, Tong Wei, Chenxiang Tang, Yun Yang, Zefeng Wang · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  51. Messenger RNA vaccines for cancer immunotherapy: progress promotes promise
    Amanda L. Huff, Elizabeth M. Jaffee, Neeha Zaidi · 2022 · Journal of Clinical Investigation
  52. High-Throughput In Vivo Screening Identifies Differential Influences on mRNA Lipid Nanoparticle Immune Cell Delivery by Administration Route
    Alex G. Hamilton, Kelsey L. Swingle, Ajay S. Thatte, Alvin J. Mukalel, Hannah C. Safford, Margaret M. Billingsley, Rakan D. El-Mayta, Xuexiang Han, Benjamin E. Nachod, Ryann A. Joseph et al. · 2024 · ACS Nano
  53. Rational formulation and industrial manufacturing of lipid-based complex injectables: Landmarks and trends
    Mariana Biscaia-Caleiras, Nuno André Fonseca, Ana Sofia Lourenço, João Nuno Moreira, Sérgio Simões · 2024 · Journal of Controlled Release
  54. Immunological Analysis of a CCHFV mRNA Vaccine Candidate in Mouse Models
    Touraj Aligholipour Farzani, Katalin Földes, Koray Ergünay, Hakan Gürdal, Aliye Baştuğ, Aykut Özkul · 2019 · Vaccines
  55. Development of lipid-like materials for RNA delivery based on intracellular environment-responsive membrane destabilization and spontaneous collapse
    Hiroki Tanaka, Yu Sakurai, Jessica Anindita, Hidetaka Akita · 2020 · Advanced Drug Delivery Reviews
  56. Systemic modified messenger RNA for replacement therapy in alpha 1-antitrypsin deficiency
    Karadagi, Ahmad, Cavedon, Alex G., Zemack, Helen, Nowak, Greg, Eybye, Marianne E., Zhu, Xuling, Guadagnin, Eleonora, White, Rebecca A., Rice, Lisa M., Frassetto, Andrea L. et al. · 2020 · Scientific Reports
  57. Ribozyme Assays to Quantify the Capping Efficiency of In Vitro-Transcribed mRNA
    Irena Vlatkovic, János Ludwig, Gábor Boros, Gábor Tamás Szabó, Julia Reichert, Maximilian C. R. Buff, Markus Baiersdörfer, Jonas Reinholz, Azita J. Mahiny, Uğur Şahin et al. · 2022 · Pharmaceutics
  58. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses
    Ye Zeng, Oscar Escalona-Rayo, Renzo A. Knol, Alexander Kros, Bram Slütter · 2022 · Biomaterials Science
  59. Biodegradable Lipid-Modified Poly(Guanidine Thioctic Acid)s: A Fortifier of Lipid Nanoparticles to Promote the Efficacy and Safety of mRNA Cancer Vaccines
    Kai Yang, Bing Bai, Jiaqi Lei, Xinyang Yu, Shaolong Qi, Yangfan Wang, Feihe Huang, Zaizai Tong, Guocan Yu · 2024 · Journal of the American Chemical Society
  60. mRNA vaccines: a new era in vaccine development
    Shubhra Chandra, Jennifer C Wilson, David M. Good, Ming Qian Wei · 2024 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  61. Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components
    Fan Wu, Nei Li, Yi Xiao, Rohan Palanki, Hannah M. Yamagata, Michael J. Mitchell, Xuexiang Han · 2025 · Small Methods
  62. Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications
    Máté Vadovics, Wenchen Zhao, Emily F. Daley, Kieu Lam, Owen M. Daly, Khalid Rashid, Hailey R. Lee, Petra Schreiner, Kendall A. Lundgreen, Brian T. Gaudette et al. · 2025 · Nature Nanotechnology
  63. Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells
    Oliwia Andries, Marina De Filette, Stefaan C. De Smedt, Jo Demeester, Mario Van Poucke, Luc J. Peelman, Niek N. Sanders · 2013 · Journal of Controlled Release
  64. Using RNA as Molecular Code for Programming Cellular Function
    Manish Kushwaha, William Rostain, Satya Prakash, John N. Duncan, Alfonso Jaramillo · 2016 · ACS Synthetic Biology
  65. Genetic medicines for CF: Hype versus reality
    Alton, Eric W.F.W., Boyd, A. Christopher, Davies, Jane C., Gill, Deborah R., Griesenbach, Uta, Harrison, Patrick T., Henig, Noreen, Higgins, Tracy, Hyde, Stephen C., Innes, J. Alastair et al. · 2016 · Pediatric Pulmonology
  66. Human RNase 4 improves mRNA sequence characterization by LC–MS/MS
    Eric J. Wolf, Sebastian Grünberg, Nan Dai, Tien-Hao Chen, Bijoyita Roy, Erbay Yigit, Ivan Reis Correa Junior · 2022 · Nucleic Acids Research
  67. Challenges and emerging trends in liquid chromatography-based analyses of mRNA pharmaceuticals
    Szabolcs Fekete, Catalin E. Doneanu, Balasubrahmayam Addepalli, Maissa M. Gaye, Jennifer M. Nguyen, Bonnie A. Alden, Robert E. Birdsall, Duanduan Han, Giorgis Isaac, Matthew A. Lauber · 2022 · Journal of Pharmaceutical and Biomedical Analysis
  68. Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery
    Geonhee Han, Dahye Noh, Hokyung Lee, Sangmin Lee, Sehoon Kim, Hong Yeol Yoon, Lee Soo Hyeon · 2023 · Advanced Drug Delivery Reviews
  69. Design and assessment of engineered CRISPR–Cpf1 and its use for genome editing
    Bin Li, Chunxi Zeng, Yizhou Dong · 2018 · Nature Protocols
  70. The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
    Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, Luis Alberto Breda Mascarenhas, Leone Peter Correia da Silva Andrade, Vinícius Pinto Costa Rocha, Milena Botelho Pereira Soares, Peter Berglund, Malcolm S. Duthie, Steven G. Reed et al. · 2021 · Vaccines
  71. Therapeutic mRNA Engineering from Head to Tail
    Longfei Jia, Shu‐Bing Qian · 2021 · Accounts of Chemical Research
  72. Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for Immunotherapy
    Christoph Wilhelmy, Isabell Sofia Keil, Lukas Uebbing, Martin A. Schroer, Daniel Franke, Thomas Nawroth, Matthias Barz, Uğur Şahin, Heinrich Haas, Mustafa Diken et al. · 2023 · Pharmaceutics
  73. Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines
    Yeung Wu, Sinuo Yu, Irene de Lázaro · 2024 · Nanoscale
  74. Efficient circular RNA synthesis for potent rolling circle translation
    Yifei Du, Philipp Konrad Zuber, Huajuan Xiao, Xueyan Li, Yuliya Gordiyenko, Venki Ramakrishnan · 2024 · Nature Biomedical Engineering
  75. Optimized conditions for successful transfection of human endothelial cells with in vitro synthesized and modified mRNA for induction of protein expression
    Meltem Avci‐Adali, Andreas Behring, Timea Keller, Stefanie Krajewski, Christian Schlensak, Hans Peter Wendel · 2014 · Journal of Biological Engineering
  76. Cardiac progenitors and paracrine mediators in cardiogenesis and heart regeneration
    Nevin Witman, Chikai Zhou, Niels Grote Beverborg, Makoto Sahara, Kenneth R. Chien · 2019 · Seminars in Cell and Developmental Biology
  77. Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape
    André E. Nel, Jeff F. Miller · 2021 · ACS Nano
  78. Alkylative damage of mRNA leads to ribosome stalling and rescue by trans translation in bacteria
    Erica N. Thomas, Kyusik Q. Kim, Emily P McHugh, Thomas Marcinkiewicz, Hani S. Zaher · 2020 · eLife
  79. An Update on mRNA-Based Viral Vaccines
    Subbiah Jeeva, Ki‐Hye Kim, Chong Hyun Shin, Bao‐Zhong Wang, Sang‐Moo Kang · 2021 · Vaccines
  80. Self-assembled Messenger RNA Nanoparticles (mRNA-NPs) for Efficient Gene Expression
    Hyejin Kim, Yongkuk Park, Jong Bum Lee · 2015 · Scientific Reports
  81. Translating the epitranscriptome
    Thomas Philipp Hoernes, Matthias David Erlacher · 2016 · Wiley Interdisciplinary Reviews - RNA
  82. Modified mRNA as a Therapeutic Tool for the Heart
    Keerat Kaur, Lior Zangi · 2020 · Cardiovascular Drugs and Therapy
  83. An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages
    Hamid Motamedi, Marzie Mahdizade Ari, Shirin Dashtbin, Matin Fathollahi, Hadi Hossainpour, Amirhooshang Alvandi, Jale Moradi, Ramin Abiri · 2021 · International Immunopharmacology
  84. mRNA vaccines in the prevention and treatment of diseases
    Yangzhuo Gu, Jiangyao Duan, Na Yang, Yuxin Yang, Xing Zhao · 2022 · MedComm
  85. Synthetic biology devices and circuits for RNA-based ‘smart vaccines’: a propositional review
    Oliwia Andries, Tasuku Kitada, Katie Bodner, Niek N. Sanders, Ron Weiss · 2015 · Expert Review of Vaccines
  86. Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA
    Blakney, Anna K., McKay, Paul F., Christensen, Dennis, Yus, Bárbara Ibarzo, Aldon, Yoann, Follmann, Frank, Shattock, Robin J. · 2019 · Journal of Controlled Release
  87. Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination
    Aurélien Sokal, Paul Bastard, Pascal Chappert, Giovanna Barba Spaeth, Slim Fourati, Alexis Vandenberghe, Pauline Lagouge-Roussey, Isabelle Meyts, Adrian Gervais, Magali Bouvier‐Alias et al. · 2022 · The Journal of Experimental Medicine
  88. Advances in the design and delivery of RNA vaccines for infectious diseases
    Abhijeet Girish Lokras, Thomas Rønnemoes Bobak, Saahil Sandeep Baghel, Federica Sebastiani, Camilla Foged · 2024 · Advanced Drug Delivery Reviews
  89. Pseudouridine as a novel biomarker in prostate cancer
    Jennifer A. Stockert, Rachel Weil, Kamlesh Kumar Yadav, Natasha Kyprianou, Ashutosh Kumar Tewari · 2020 · Urologic Oncology Seminars and Original Investigations
  90. Regulation of antiviral innate immunity by chemical modification of viral RNA
    Na Li, Tariq M. Rana · 2022 · Wiley Interdisciplinary Reviews - RNA
  91. Innate immune regulations and various siRNA modalities
    Anju Kaushal · 2023 · Drug Delivery and Translational Research
  92. Characterization of mRNA therapeutics
    Guilherme J. Guimaraes, Jaeah Kim, Michael G. Bartlett · 2023 · Mass Spectrometry Reviews
  93. Computational design of mRNA vaccines
    Yoo-Ah Kim, Kambiz Mousavi, A Khalili Yazdi, Magdalena Zwierzyna, Marco Cardinali, Dillion M. Fox, Thomas Peel, Jeff Coller, Kunal Aggarwal, Giulietta Maruggi · 2023 · Vaccine
  94. Complex Coacervates as a Promising Vehicle for mRNA Delivery: A Comprehensive Review of Recent Advances and Challenges
    Chloe Forenzo, Jessica Larsen · 2023 · Molecular Pharmaceutics
  95. The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods
    Yekta Metanat, Patrik Viktor, Ayesha Amajd, Irwanjot Kaur, Ashraf Mohammed Hamed, Noor K. Abed Al-Abadi, Nathera Hussin Alwan, MVNL Chaitanya, Lakshmaiya Natrayan, Pallavi Ghildiyal et al. · 2024 · Life Sciences
  96. Exogenous RNA surveillance by proton-sensing TRIM25
    Myeonghwan Kim, Youngjoon Pyo, Seong‐In Hyun, Minseok Jeong, Yeon Choi, V. Narry Kim · 2025 · Science
  97. Self-assembled miRNA-switch nanoparticles target denuded regions and prevent restenosis
    John H. Lockhart, Jeffrey VanWye, Richa Banerjee, Samuel A. Wickline, Hua Pan, Hana Totary-Jain · 2021 · Molecular Therapy
  98. Nanoparticle-Mediated In Situ Molecular Reprogramming of Immune Checkpoint Interactions for Cancer Immunotherapy
    Adam Alexander Walters, Gemma Santacana-Font, Jin Li, Nadia Routabi, Yue Qin, Nathalie Claes, Sara Bals, Julie T.-W. Wang, Khuloud T. Al‐Jamal · 2021 · ACS Nano
  99. Microfluidic Platform Enables Shearless Aerosolization of Lipid Nanoparticles for mRNA Inhalation
    Jeonghwan Kim, Antony Jozić, Elissa Bloom, Brian Jones, Michael Marra, Namratha Turuvekere Vittala Murthy, Yulia Eygeris, Gaurav Sahay · 2024 · ACS Nano
  100. Aptamer-based assembly systems for SARS-CoV-2 detection and therapeutics
    Yuhang Dong, Jingping Wang, Ling Chen, Haonan Chen, Shuangbo Dang, Feng Li · 2024 · Chemical Society Reviews